AKOYA BIOSCIENCES INC (AKYA)

US00974H1041 - Common Stock

3.82  +0.01 (+0.26%)

After market: 3.82 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
54.92M
29.41%		74.86M
36.31%		96.633M
29.08%		118.08M
22.19%
EBITDA
YoY % growth
-34.51M
-321.37%		-58.96M
-70.85%		-48.778M
17.27%		-26.417M
45.84%
EBIT
YoY % growth
-39.3M
-227.23%		-66.11M
-68.22%		-57.668M
12.77%		-36.82M
36.15%
Operating Margin
-71.56%-88.31%-59.68%-31.18%
EPS
YoY % growth
-4.52-1.88
58.41%		-1.43
23.94%		-0.86
40.17%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.29
40.15%
Revenue
Q2Q % growth		24.767M
15.68%
EBITDA
Q2Q % growth		-10.559MN/AN/AN/AN/A
EBIT
Q2Q % growth		-13.503M
22.57%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.22
56.00%		-0.270.0519.69%
Q3 2023
Q2Q % growth		 -0.26
44.68%		-0.370.1130.30%
Q2 2023
Q2Q % growth		 -0.46
2.13%		-0.45-0.01-1.83%
Q1 2023
Q2Q % growth		 -0.49
-11.36%		-0.490.000.51%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 26.487M
24.82%		26.408M79K0.30%
Q3 2023
Q2Q % growth		 25.22M
33.79%		25.031M189K0.76%
Q2 2023
Q2Q % growth		 23.52M
31.47%		22.887M633K2.77%
Q1 2023
Q2Q % growth		 21.41M
26.76%		20.727M683K3.30%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.6% -6.48% 6.55% 15.64%
Revenue-0.75% -6.92% -1.38% -3.51%